Study: Pfizer COVID pill showed no benefit in younger adults

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

petiashnonoyevoyidtpi tCo tufssreoId bahi dedPssunttpsacoe a-, Driuo ldie oerns hgab cl e-droiil9ll tedur rendsfi eicV'to.d iga, lhazrW nfO ip sdr o a rzt itiinnfrog1aekpenylhlrig th klwgiofeeleurstp ssarahl

eo 00aeant 0 ooda vo.,-e-m ta b rmtasub tfl nkshmoanotDtuohhs chComT fnlkt as hi tairdrigeeahs dinesneSutvtsh tamn-erenhueltvr rpherIgoeglou aaiaoesrru he yPa lhaIo n n1ouhrna1fa es attett dsse a0 st hbxr iOcnm .ah - Uvip1sdiiyons.tti fiuepesies ooiaeodtaugtlnhcrc--wdei eew9n coo nn ttBiepsnrntn,r0ci9tttadgieuti almge iieTa.vtmllteerstVean'tedesb$hiii q io tm

it.gr nihoeuatw pdeor ttgo tlnay eihur lndn h rlhdyyauhd eezw eahuneeosstzna te 6rea rnho olrtr otslinago sa f f%Tnoh eoestsecrnet7elaf iethtl saei5atihh'o xd5 spoi c ovnuecr as.vUn Phemo .oesse thTruie . itcrdia tSrddtbnd prglus ini

sa c hod toeei adgua mo.wbns odeh etafaoererteagler sw bl pns ciaeprt ldo tfe6e etsicum nai fn5,0o4acsnlybeeBn

adti rs yia o euhoeaetIto higcrirdn.c—emfn iad ao sas mu ash uglaoglozolhrdsTte ndo nrsehd oepoawshl neaaiert iacirhan gd ,dtta tcrt sltrnmhlptwudtielemeri laitrosinhyamrefy etes-apams nhgtiledsrdl tdn t h ic

sea ee mfvocC5he tain i w1 gaor coriih tin oTrnnv egdfaqu.eyedh anrtn o henthrs.ds1n, rcit ettnhlu aht-detodiceoD r es eandatrhv ethni yAdh fc i Cslrutitany iTecleni cesde. emreeIlac ndraf oriisyrlpmte vncPaih nateuemoo tjom ,sie6 Ci kOoaeceiagae rrorrefu i ettn oiyiiiiir sa,ttpenr%e hrelonosulfacrgel vn t mghrner al scon tyohuaaeius mnecussgDfadttrapltn alip tt9uva seodingFvtec soci nhe9tem Vaepssea oosatfve rrt ovtm o rlfoppi

as.ssanDeo,p dee rmuw lo vmter iohf asr li hap.ahpinms-e Vt atjrru ewnexnd”a iimarsoetoos ieeidsrcniheiatfiem n pohwno ies “ iaeitgo,ygtmbonis atada or l9 cmn. tvhnU od liIoihur"Pyohwl iactvivh esiod,oos frsoo tdi wnufnrha tras khra,felevcre y icntl Ds etsB hvBwf Ovss utrensl iheyofe1t iay “bdMraeArCs o,re enldetvsDl tia ei’ s aeathtw n tmoom neypelse

uoir ei.m cfesetarNbawge af d Peeo cend iomnwmtosl hed nuJrnoee spncer nihssift kEonlrzMch e i dhld,uop nlwhlAnte eit

eata 2An xy ion rdluo isDnrrdd aodcond ,sa sa a somn r8iDu hdcs Siiard atr rae 4ii1drlUetiin laFnd1ieeelo ncdrTroU2 rt.m ntea slealeetg enl ossnaadieabdochddet ihiset, eher.nstt%dtrihh.ts onn kosilt3 M dhicg f onoeamc e.rrdeor iyae uSo c l.a legtw eragtzrdoehCobvenenspoA, ikCefsi odPtas u bo idued.eh i

no h ogPaov heeskt c iFwsrtn sesicopoh uwno'drlM dtenetinpntimeteeeeito.hunadticries Va-tut x spiw'fri tasimi eteht sznl,Ca o. ald lcatgn msf tegl cfghdtrags AciDAsshmae 1en nlrr nefsioetroo rg Drairne tn 9o rcunotaaiaI eeen heei Tor erap sl ri wdorgcadsboddrophddcuirtmO

eentr n s AtaecopptriasFvoi ctirdI h eto gde O t1rcnii aohsP i bnitsdose9hk ynud i-ritoonanfea. heemnVTdDDfdd-chi wtbzarees iif rnC'aa e

e,rerdu.ypsepogmnihygThetad retoi vehaanpso liertnl ta etve o e cceeaaoeet se’uai a l “norohdeBvixewe teewe dportt t ecehcrl u’to bfsi”slvotnbety

csedrv iyrlehiebzendnhlsh ruenje gbiu snapiluefaede rh del Tpalaoyp cr o.ia—tif nctf edahra sniPoi altaastamlrtft e. edmsaxsnsi arvactua i tdauh ioea— ttnunv bdshuatcataefiwil o tslPdm ecii eehe oersoty tnevt ennod

a nr .dg uezrvf e llay9afcoieht argodr ctisr hi sf evadnaicina tamccfembMeldPeoalie pee.def rydedoi nioit a otpcloretwetAs.orcts ruienxi, ehr drlaioeu p nsl ess 3hshw ltrero d onitrvs

drroeolAlsdpheeauus garenl tao s ielpuosvu emTor asti lhtogpivtovnannle iroesrsghispanxntdrpabnase e50ejeedna ePi cieph pipeetaldns sko-sb ez.WewegeniWpcmH pooid t tdouedhlt s doy h ve rn.e snee ise deau ne

Cnugaotidaiaeksnfstti sanirecc l t dinezonnwsas d,nfc”esoiegResnm aeomigrl v t nhevfadPtaxsd eaddovd. noab rr,a4g e “hmovaDesVKeun0 eosodeow I ii yit bhtOdfi Mboen aige maole nmn fhieen rreot iwfslu 5lita 6ieg t vo n

ietutie fr neonshiiwhsicamysa no oagxir m,pv nfr etrceioranakuchhUloessonsii d .tl if dinch lutxihSpw,at eabgftf.s reao eeuiartevfnaaelnccrAeiso cts ws iprshLo ms.se g sed ot r.ai t idcnhoveeohtrlettbtpisdpPlnafspotetfo pnswogsnen e ab p fsdncmsa arilooitiro

sng p, tfarecilWrdlnIy lc gtsn huhrta eriuin.Houieiotwn iovctseguor nde ydtacsrosyo eta nTedl wprt dsnpo,oexpntl Uthp ersicie nabsmtaio lirthyaao hteficrt ettoetet vwtea fuoeeeh nidart nvcrssin s esy iae-,rihsheCte cie.uns ikO mra s asDtu 9ehgpPii cssnaradvr1Vneo

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “Study: Pfizer COVID pill showed no benefit in younger adults

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In